Nov 2026· European Journal of Heart Failure· 0 citations
Medicine
TL;DR
In ICD recipients with persistent LV dysfunction following MI, VA and HF events are bidirectionally associated and independently associated with mortality and the VA-HF association was strongest for shock-treated arrhythmias.
The electrical risk score (ERS) was associated with ventricular arrhythmia-related ICD shocks in HF patients undergoing primary prevention ICD implantation and may identify patients at increased arrhythmic risk and guides follow-up and ICD management.
Pelin Aladağ, I. Erbay, N. E. Güdül et al.· Journal of Clinical Medicine· 0 citations
Previous randomized trials have demonstrated a survival benefit of implantable cardioverter-defibrillator (ICD) therapy in patients with reduced left ventricular ejection fraction (LVEF). However, advances in heart failure therapy and post–myocardial infarction (MI) management over the past decade may have modifi...
T. Chiba, A. Sepehri Shamloo, G. Hindricks et al.· European Heart Journal· 0 citations
In this cohort, MWI dispersion showed the highest single-parameter discrimination for VAs among the echocardiographic variables tested, and its combination with RA area gave the best model.
M. Dąbrowska, M. Potapowicz-Krysztofiak, Patrycja Życzkowska et al.· Biomedicines· 0 citations
BACKGROUND
A subset of patients with advanced heart failure (HF) supported with durable left ventricular assist devices (LVADs) demonstrate significant improvement in left ventricular ejection fraction (LVEF), but the impact of such functional improvement on clinical outcomes is unclear.
METHODS
We analyzed adults in...
E. Maneta, I. Kyriakoulis, C. Kyriakopoulos et al.· Journal of Cardiac Failure· 0 citations
In patients with heart failure (HF) and reduced left ventricular ejection fraction, guideline-directed medical therapy improves survival. For advanced HF refractory to medical and device therapies, durable left ventricular assist device (LVAD) implantation is indicated. Although LVADs provide substantial left ven...
T. Kondo, S. Kazama, T. Imaizumi et al.· European Heart Journal· 0 citations
The benefit of primary prevention implantable cardioverter defibrillator (ICD) in heart failure (HF) patients aged ≥75 years, particularly those with significant non-cardiac comorbidities, is questionable. We aimed to evaluate the clinical yield of primary prevention ICD in late-elderly HF patients.
A mult...
A. Brin, O. Koren, A. Demitriev et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.